Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: services market access outcomes strategy payer pricing research
… countries, and localities, with widening gaps in access, quality, and affordability of healthcare. But what … volatile and highly competitive global pharmaceutical market, demonstrating value to support launch of medicines … the value of integrated evidence generation. Related Services Health Economics Pharmacoepidemiology and Risk …
… contributed by: Shahnaz Khan, MPH , Executive Director, Market Access and Outcomes Strategy at RTI Health Solutions FDA … on incidence and prevalence) Product-related programs or services Factual presentations of results from studies, …
… state, disease progression, and available therapies, so market segments can emerge from these experiments. Below is … actionable results to inform your drug development and market access strategies. For your project, we conduct the …
… actionable results to inform your drug development and market access strategies. For your project, we conduct the …
… therapeutic areas . Our diverse background in clinical research, regulatory submissions, epidemiology studies, and … in pharmacoepidemiology Conducting epidemiological research related to pregnancy Based on your needs, we provide … projects or can set up long-term arrangements that allow access to specific experts on an ongoing basis. For example, …
… Naoko Ronquest (she/her), PhD, Executive Director, US HTA Strategy and Early Modeling and Kyle Paret , PhD, Associate … information ahead of first availability of the study outcomes Strengthen trial recruitment strategy to ensure that … To reflect future Centers for Medicare & Medicaid Services price negotiation under the Inflation Reduction Act, …
Navigating EU Joint Clinical Assessments and Joint Scientific Consultations From January 2025 Onward
… transparency, and timeliness of clinical HTAs so that access to innovative medicines is accelerated for EU … the need for joint ownership of regulatory affairs and market access functions on an EU level. Given the timeline … of strategy, planning, evidence preparation, and support services. Given the 3-month cut-off for the JCA dossier, …
… to help our clients develop strategies in the dermatology market and to develop and gain market access for products to treat cutaneous diseases and … reviews Global Value Dossiers Meta-analysis studies Outcomes research strategy development Patient-reported …
… MEd, MA Head, Economic QUalitative Inquiry, Policy, and Access RTI Health Solutions This is part two of a three-part … entities are tasked with ensuring that their products and services are accessible and beneficial to all people, … companies to address multiple, interconnected outcomes. We know that health disparities lead to lower …
… Integrated Evidence Generation Strategy Long-Range Planning for Improved Alignment and … commercial collaboration in pursuit of optimizing patient outcomes. …